THE ANALYSIS OF INFLUENCE OF CLINICAL PREDICTORS ON THE RESULTS OF TREATMENT WITH ERLOTINIB IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Salajka, Frantisek [1 ]
Pesek, Milos [2 ]
Krejci, Jana [3 ]
Skrickova, Jana [4 ]
Zatloukal, Petr
Koubkova, Leona
Grygarkova, Ivona
Hrnciarik, Michal [1 ]
Sticha, Michal [5 ]
机构：
[1] Univ Hosp, Dept Pneumol, Bulovka, Czech Republic
[2] Univ Hosp Plzen, Dept Pneumol, Plzen, Czech Republic
[3] Charles Univ Hosp Plzen, Dept Pneumol, Plzen, Czech Republic
[4] Univ Hosp Brno, Dept Resp Dis & Tb, Brno, Czech Republic
[5] Masaryk Univ, CS-60177 Brno, Czech Republic
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; erlotinib; clinical predictors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1293 / S1294
页数：2
相关论文
共 50 条
  • [1] ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT
    Goncalves, Ivone M.
    Monteiro, Regina
    Neves, Sofia
    Conde, Sara
    Campainha, Sergio
    Parente, Barbara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1298 - S1298
  • [2] EXPERIENCE OF USING ERLOTINIB FOR TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Kanazawa, Kenya
    Ishida, Takashi
    Suzuki, Aya
    Tachihara, Motoko
    Minemura, Hiroyuki
    Sekine, Satoko
    Oshima, Kengo
    Yokouchi, Hiroshi
    Watanabe, Kana
    Tanino, Yoshinori
    Munakata, Mitsuru
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1310 - S1310
  • [3] Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer
    Marco Platania
    Francesco Agustoni
    Barbara Formisano
    Milena Vitali
    Monika Ducceschi
    Filippo Pietrantonio
    Nicoletta Zilembo
    Francesco Gelsomino
    Sara Pusceddu
    Roberto Buzzoni
    Targeted Oncology, 2011, 6 : 181 - 186
  • [4] Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer
    Platania, Marco
    Agustoni, Francesco
    Formisano, Barbara
    Vitali, Milena
    Ducceschi, Monika
    Pietrantonio, Filippo
    Zilembo, Nicoletta
    Gelsomino, Francesco
    Pusceddu, Sara
    Buzzoni, Roberto
    TARGETED ONCOLOGY, 2011, 6 (03) : 181 - 186
  • [5] Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC)
    Tiseo, Marcello
    Andreoli, Roberta
    Gelsomino, Francesco
    Mozzoni, Paola
    Azzoni, Cinzia
    Bartolotti, Marco
    Bortesi, Beatrice
    Goldoni, Matteo
    Silini, Enrico Maria
    De Palma, Giuseppe
    Mutti, Antonio
    Ardizzoni, Andrea
    LUNG CANCER, 2014, 83 (02) : 265 - 271
  • [6] Review of erlotinib in the treatment of advanced non-small cell lung cancer
    Ganjoo, Kristen N.
    Wakelee, Heather
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04) : 335 - 346
  • [7] Efficacy and clinical/molecular predictors of erlotinib monotherapy for Chinese advanced non-small cell lung cancer
    Zhu Yu-jia
    Xia Ying
    Ren Guan-jun
    Wang Meng-zhao
    Zeng Xuan
    Zhang Li
    CHINESE MEDICAL JOURNAL, 2010, 123 (22) : 3200 - 3205
  • [8] Comparing Efficacy of Erlotinib and Bevacizumab Combination with Erlotinib Monotherapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis
    Sakharkar, Prashant
    Kurup, Sonali
    DISEASES, 2023, 11 (04)
  • [9] Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer
    Zhou, Songwen
    Ren, Shengxiang
    Yan, Lianghua
    Zhang, Ling
    Tang, Liang
    Zhang, Jie
    Zhou, Caicun
    RESPIROLOGY, 2009, 14 (05) : 709 - 715
  • [10] Retrospective Analysis of Clinical Efficacy of Erlotinib in Patients with Non-Small Cell Lung Cancer
    Ayyildiz, Aylin
    Kanat, Ozkan
    Ozkaya, Guven
    Deligonul, Adem
    Gursoy, Vildan
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2015, 6 (02) : 212 - 215
12345